ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumourBadreddin Edris, Matt van de Rijn, Thomas Mühlenberg et al.|The Journal of Pathology|2012Cited by 77
Gene expression analysis identifies two groups of ovarian high-grade serous carcinomas with different prognosisÍñigo Espinosa, Jaime Prat|Modern Pathology|2011Cited by 32